As a FDA clinical eye research center, Feinerman Vision Center, is always seeking new technologies and innovative eye care solutions to better our patients’ experience. In the medical field, emerging technologies give us and qualified patients an opportunity to participate in upcoming, advanced clinical research studies as a safe and effective way to improve eye care.
Periodically, we will conduct clinical research studies that comprise of new procedures, treatments, IOLs & other lens types, and eye medication.
As a qualified patient, you can choose to participate in any of these clinical research studies. Depending on the specific study, compensation is sometimes available and can vary. Please ask our staff.
Patient Recruitment for Clinical Research Studies:
SENJU CHALAZION STUDY
Do you have a Red Swollen Bump on your upper/lower eyelid?
You may be eligible to participate in a research study.
- An eyelid chalazion that has been present for less than 3 weeks.
- Participate in a clinical trial for a period of 3 weeks.
*Study-related care will be provided at no cost and travel compensation is provided for required visits.
To learn more about the study, please call 949-631-4780 or email Sheila@FeinermanVision.com
BAUSCH + LOMB CLINICAL RESEARCH STUDY
Have you been told you have a cataract and astigmatism?
You may qualify to take part in a clinical research study of an investigational intraocular lens that is designed to treat patients with a cataract who also have astigmatism. We are participating in this new study conducted by Bausch + Lomb here in our Newport Beach office.
If you take part in the study you will be asked to return to our office for examinations to evaluate your vision. These visits are at no cost to you.
As a participant you will receive:
- All study-related exams at no cost
- Intraocular lens at no cost
- Some routinely-prescribed eye drops at no cost
- Compensation for time and travel
Closed to Enrollment
Feinerman Vision Center is currently recruiting volunteers to participate in a clinical research study for individuals over 40 years of age who are having cataract surgery. A clinical trial is being conducted to determine the effectiveness, safety, and tolerability of two different dosages of an investigational medication compared with placebo (an inactive substance). The study medication is injected in the eye at the end of cataract surgery to determine if it can reduce inflammation (a signal of the body to start the healing process characterized by redness, pain, swelling) associated with ocular surgery. To determine eligibility, interested individuals will be examined by Dr. Gregg Feinerman, M.D. as part of a screening visit prior to surgery. After the cataract surgery, there will be at least six follow-up visits that will take place over ninety days. Qualified participants will receive study medication at no cost and compensation for study visits.
For further information about this study, please contact Sheila at 949-631-4780 or Sheila@FeinermanVision.com.
Cataract Medication Study
Closed to enrollment.
Crystalens for Astigmatism FDA Study
Closed to enrollment.